Fresenius Historical Cash Flow
| 0H9X Stock | 45.50 0.05 0.11% |
Analysis of Fresenius Medical cash flow over time is an excellent tool to project Fresenius Medical Care future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 1.3 B or Dividends Paid of 370.4 M as it is a great indicator of Fresenius Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Fresenius Medical Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fresenius Medical Care is a good buy for the upcoming year.
Fresenius |
About Fresenius Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Fresenius balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Fresenius's non-liquid assets can be easily converted into cash.
Fresenius Medical Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Fresenius Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Fresenius Medical's Change In Working Capital is comparatively stable compared to the past year. Total Cash From Operating Activities is likely to gain to about 2.8 B in 2024, despite the fact that Change In Cash is likely to grow to (177.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Dividends Paid | 392.5M | 395.6M | 454.9M | 370.4M | Depreciation | 1.5B | 1.7B | 1.9B | 1.3B |
Fresenius Medical cash flow statement Correlations
Click cells to compare fundamentals
Fresenius Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fresenius Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (10.3M) | 10.2M | (583.9M) | (353.3M) | (318.0M) | (302.1M) | |
| Change In Cash | (1.1B) | 73.8M | 400.1M | (207.9M) | (187.1M) | (177.7M) | |
| Change In Working Capital | 231.7M | (153.0M) | (833.7M) | 685.2M | 788.0M | 827.4M | |
| Total Cashflows From Investing Activities | (3.3B) | (1.3B) | (1.2B) | (734.7M) | (844.9M) | (887.2M) | |
| Other Cashflows From Financing Activities | (228.0M) | (319.7M) | (279.5M) | (218.9M) | (197.0M) | (206.9M) | |
| Depreciation | 1.6B | 1.6B | 1.5B | 1.7B | 1.9B | 1.3B | |
| Dividends Paid | 354.6M | 351.2M | 392.5M | 395.6M | 454.9M | 370.4M | |
| Capital Expenditures | 1.1B | 1.1B | 1.1B | 854.4M | 724.0M | 0.0 | |
| Total Cash From Operating Activities | 2.6B | 4.2B | 2.5B | 2.2B | 2.5B | 2.8B | |
| Net Income | 1.2B | 1.2B | 969.3M | 673.4M | 499.0M | 946.2M | |
| Total Cash From Financing Activities | (466.6M) | (2.7B) | (1.0B) | (1.6B) | (1.5B) | (1.5B) | |
| Other Cashflows From Investing Activities | (20.7M) | 897.3M | (2.1B) | (249.7M) | (224.7M) | (236.0M) | |
| Change To Inventory | (117.5M) | (355.8M) | (48.5M) | (204.3M) | (183.9M) | (193.1M) | |
| Investments | (18.0M) | (65.1M) | (61.6M) | (71.3M) | (82.0M) | (86.1M) | |
| Net Borrowings | 700.0M | (1.6B) | (358.9M) | (1.0B) | (920.7M) | (874.7M) | |
| Change To Account Receivables | (64.1M) | 71.7M | (163.2M) | (46.7M) | (53.7M) | (56.4M) | |
| Change To Operating Activities | (46.1M) | (178.5M) | 164.2M | 154.0M | 177.1M | 186.0M | |
| Change To Netincome | (173.6M) | 246.4M | 32.6M | (98.1M) | (112.8M) | (118.4M) | |
| Change To Liabilities | (164.8M) | 1.4B | (364.0M) | (356.8M) | (321.1M) | (305.1M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.